fluorescent proteins with emission wavelengths in the nearinfrared and infrared range are in high demand for whole-body imaging techniques. here we report near-infrared dimeric fluorescent proteins eqfP650 and eqfP670. to our knowledge, eqfP650 is the brightest fluorescent protein with emission maximum above 635 nm, and eqfP670 displays the most red-shifted emission maximum and high photostability.
localization, cell migration, embryogenesis and other studies involving deep-tissue imaging. Although an infrared protein that requires biliverdin injection for fluorescence has been reported recently 4 , fully genetically encoded markers are preferable. Here we report near-infrared fluorescent proteins based on the dimeric far-red fluorescent protein Katushka 2 .
For whole-body imaging experiments, high reporter expression is usually required, and low cytotoxicity is crucial 5 . According to our experience, Katushka is not cytotoxic, as we have generated stable lines of transgenic Xenopus laevis 2 and Danio rerio ( Supplementary  Fig. 1 ) expressing Katushka in muscle cells at high levels.
However, a recent report has suggested that more optimal low-toxicity fluorescent protein variants can be selected using a bacterial expression system 5 . We performed a similar screen (Online Methods) and identified a low-cytotoxicity Katushka variant named Katushka-9-5, which had spectral characteristics nearly identical to those of Katushka and had minimal negative impact on bacterial growth, in contrast to Katushka (m)Neptune, a recently reported monomeric far-red fluorescent protein 6 (Supplementary Fig. 2 ). Neither Katushka-9-5 nor Katushka demonstrated any visible cytotoxicity when expressed in mammalian HeLa cells (Supplementary Fig. 3 ). To compare cytotoxicity of Katushka-9-5 and Katushka in vivo, we microinjected plasmids in the animal poles of X. laevis embryos at the two-cell stage (20 pg per blastomere), and tracked the death rate by the tailbud stage (stage 25) and by the tadpole stage (stage 42). These experiments demonstrated lower toxicity of Katushka-9-5 compared to Katushka (Fig. 1a) . Because of its lower toxicity, we selected Katushka-9-5 for the development of fluorescent protein variants with further redshifted emission. Based on the crystal structure of the related far-red fluorescent protein mKate 7 (Protein Data Bank (PDB): 3BXB), we selected amino acid positions in proximity to the chromophore (including Met14, Leu16, Met44, Thr62, Tyr121, Ser148, Ser165, Met167, Arg203 and Leu205) for targeted mutagenesis (numbering in accordance with Aequorea victoria GFP, avGFP; Supplementary Fig. 4 ). We performed semisaturated (two to five amino acid variants) site-directed mutagenesis of these positions in several combinations and random mutagenesis. We manually screened bacterial libraries containing these mutants using a fluorescence stereomicroscope equipped with a 650LP emission filter and a built-in spectrofluorimeter. We screened more than a million individual colonies and selected two red-shifted variants, named Entacmaea quadricolor (eq)FP650 and eqFP670, that had substitutions N24G,M44A and M14T,N24G,M44C,S14 8N,S165N, respectively. Notably, Met44 is also substituted by a small amino acid in two recently published far-red fluorescent proteins, mNeptune 6 and E2-Crimson 8 ( Supplementary Fig. 4 ). This mutation has been shown to create a cavity filled by a water molecule forming a hydrogen bond with the chromophore acylimine oxygen 6 and appears to be a universal solution for providing a bathochromic shift of the fluorescence emission for DsRed-like chromophores.
Characteristics of eqFP650 and eqFP670 are summarized in Table 1 and Figure 1 . Both proteins were characterized by fast maturation in Escherichia coli at 37 °C and demonstrated no residual short-wavelength fluorescence of intermediate or alternative chromophore forms, in contrast to E2-Crimson, which exhibits a second bright blue emission peak, and mNeptune, which has a pronounced green peak ( Supplementary Fig. 5 ). As evidence of complete chromophore maturation, the absorbance spectra of freshly purified proteins were single peaks with minor absorption bands at 340-360 nm characteristic of red fluorescent proteins (Fig. 1d) . In transiently transfected HeLa cells, eqFP650 produced the brightest signal in its spectral class (Fig. 1b) . In HEK-293T cells that provide high expression, eqFP650 produced bright signal 14 h after transfection. eqFP650 and eqFP670 had only one amino-acid substitution in the outer surface of the beta-barrel (Gly24, characteristic for avGFP and E2-Crimson, Supplementary Fig. 4 ) and both inherited the dimeric nature of Katushka-9-5, as well as its low toxicity in bacterial expression experiments (Supplementary Fig. 2) . In eukaryotic cells, eqFP650 and eqFP670 were evenly distributed and demonstrated no aggregation or toxicity (Supplementary Fig. 6 ). eqFP650 generally retained the high brightness of Katushka and was characterized by a strong bathochromic shift, with excitation and emission peaks at 592 nm and 650 nm, respectively ( Fig. 1c and Supplementary Fig. 7 ). To date, eqFP650 is the brightest fluorescent protein with emission maxima above 635 nm and should be an optimal genetically encoded marker for in vivo imaging.
eqFP670 is characterized by lower brightness but stronger bathochromic shift, with excitation and emission peaks at 605 nm and 670 nm. eqFP670 is to our knowledge the first GFP-like fluorescent protein with such long-wavelength emission, approximately half of which falls in the infrared part of the spectrum. Compared to Katushka, eqFP670 had fourfold greater infrared brightness ( Table 1) . Furthermore, eqFP670 had high pH stability ( Table 1) and extremely high photostability (Fig. 1e,f) and should allow for accumulation of the fluorescent signal over long exposure times. The combination of Asn148 and Asn165 in eqFP670 is unique and has not been encountered in other fluorescent proteins. This implies tight packing around the chromophore, which probably forms the basis of the high photostability and pH resistance.
To investigate fluorescence detection in deep tissues by wholeanimal imaging, we transiently transfected HEK 293T cells with a plasmids encoding either Katushka, eqFP650, eqFP670, mNeptune 6 or E2-Crimson 8 and injected cells intramuscularly into the gluteal region of mice. We also transfected these cells with firefly luciferase plasmid to normalize for transfection efficiency and total numbers of injected cells. Representative images of mice injected with cells expressing E2-Crimson, mNeptune or eqFP650 showed that eqFP650 had the highest fluorescence (Fig. 2a) , and quantification at various emission wavelengths showed higher fluorescence from eqFP650 at two excitation wavelengths (Fig. 2b,c) . No cell implant was detectable with 640 nm excitation and infrared detection, probably owing to the high background signal.
To compare efficiency of infrared imaging, we used another imaging system. We subcutaneously (2-mm depth) injected equal portions of mature Katushka, eqFP650, eqFP670, E2-Crimson, Neptune and mNeptune protein. Injection of protein samples provided higher local concentration of a fluorescent protein than injection of transiently transfected cells, allowing for better signalto-noise ratio. In this artificial system, all the proteins tested had comparable infrared signal (Fig. 3) . This system, however, did not account for multiple influences on fluorescent protein signal in living cells that were present in the in vivo experiment shown in Figure 2 , such as protein maturation rate, protein turnover, mRNA stability and transcription rate. We did not attempt to quantify protein expression and do not know how it may have varied.
Although we demonstrated that eqFP650 now may be the preferable near-infrared fluorescent protein for in vivo cell-labeling experiments, we believe that development of longer-wavelength fluorescent proteins such as eqFP670 with high brightness and of true monomeric variants for protein fusions will increase the sensitivity and capabilities of deep-tissue imaging techniques. methods Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
Accession codes. GenBank: HQ148301 (eqFP650) and HQ148302 (eqFP670).
online methods
Cloning and gene construction. Cloning and gene construction were performed as described in reference 2. Briefly, purification of PCR products and products of restriction digests was performed by gel electrophoresis and extraction using the QIAquick gel extraction kit (Qiagen). Plasmid DNA was purified using the QIAprep Spin Miniprep kit (Qiagen). Site-directed mutagenesis was performed by overlap-extension PCR 11 . Random mutagenesis was performed using the Diversity PCR Random Mutagenesis kit (Clontech). For bacterial expression, a fluorescent protein gene was cloned into the pQE30 vector (Qiagen) using BamHI and HindIII restriction sites. For expression in eukaryotic cells, a fluorescent protein gene was cloned instead of TurboGFP into the pTurboGFP-N vector (Evrogen) using AgeI and NotI restriction sites.
Characterization of fluorescent proteins in vitro. Fluorescent proteins were characterized as described in reference 12. Briefly, proteins were expressed in E. coli XL1 Blue strain (Invitrogen), purified using Talon metal-affinity resin (Clontech) and desalted using gel-filtration columns (Bio-Rad). Cary 100 UV/VIS Spectrophotometer and Varian Cary Eclipse Fluorescence spectrophotometer were used to measure absorption and excitationemission spectra. All measurements were performed in 100 mM NaCl with 20 mM Tris-HCl (pH 7.5). Molar extinction coefficients were calculated based on the chromophore absorption in native proteins and proteins alkali-denatured with an equal volume of 2 M NaOH, considering that in alkaline conditions DsRed-like chromophore converts to the GFP-like one 13 with an extinction coefficient of 44,000 M −1 cm −1 at 452 nm. Absorbance spectra were measured immediately after denaturation. Quantum yields were determined by direct comparison with mCherry. To measure pH stability, buffers in the pH range from 3 to 10 were used. An aliquot of purified protein was diluted in the corresponding buffer solution. After 1 h incubation at room temperature (25 °C), the fluorescence brightness was measured. In each sample, actual final pH was measured using a microelectrode (Sartorius).
Photostability. Selected proteins underwent a photostability comparison test in LSM 510 confocal scanning microscope (Carl Zeiss) and epifluorescence Leica AFLX 6000 microscope. Proteins with 6His tags were bound to Talon metal affinity resin beads, placed on a glass slide and exposed to light. The following parameters were used for bleaching by a 561 nm laser line in a confocal microscope: 63× oil-immersion objective, 1.5× zoom, 4 s per image scan rate and maximal power. For bleaching by a mercury arc lamp, a TexasRed filter set was used, which passes the 546 nm peak of a mercury lamp. Bleaching times were corrected on the molar extinction coefficients of the corresponding fluorescent protein at 546 nm or 561 nm.
Animal imaging and data analysis. HEK 293T cells were grown in DMEM (Invitrogen), 10% FBS, 1% glutamine and 0.1% penicillinstreptomycin-gentamicin. Cells were transfected with 8.7 μg of plasmid encoding various fluorescent proteins and 1 μg of plasmid encoding firefly luciferase by calcium phosphate precipitation as described previously 14 . Cells were used for experiments 2 d after transfection. The plasmid for E2-Crimson was provided courtesy of B. Glick (University of Chicago). All animal procedures were approved by the University of Michigan Committee on Use and Care of Animals. Mice were anesthetized with isoflurane and injected with 2.5 × 10 6 cells intramuscularly into the right and left gluteal musculature of each mouse. Cells were injected in 100 μl of a 1:1 mixture of F12 medium and matrigel (BD Biosciences). Imaging was performed approximately 1 h after injection. Bioluminescence and fluorescence imaging were performed on an IVIS Spectrum (Caliper) system. Fluorescence images were acquired with excitation and emission filters indicated in Figure 2 , using 3-s acquisition, small binning and 12.5-cm field of view. After fluorescence imaging, bioluminescence imaging of firefly luciferase was performed as described previously 15 . Data for fluorescence and bioluminescence were quantified as efficiency and photons, respectively. To account for differences in transfection efficiency and actual numbers of injected cells, pseudocolor displays for fluorescence images were normalized for photons for firefly luciferase in each cell implant. Data were also graphed as ratios of fluorescence efficiency to firefly luciferase photons and presented as mean values ± s.e.m. (n = 4-6 samples per point).
